Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Vivos Q3 2026 Results: Net Loss of $732K, Loss Widens

Vivos Inc. reported a net loss of $2,746,628 for the nine months ended September 30, 2026, compared to a loss of $1,987,503 in the prior year period, driven largely by a $847,628 non-operating loss on share issuances. While revenues increased significantly to $101,368 from $43,627, the company continues to operate with a substantial accumulated deficit of over $91 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue0.00.0
Gross profit0.0-0.0
Profit before tax-0.7-0.5
Net income-0.7-0.5
EPS (diluted, $ a share)$-0.00$-0.00

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+1438.1%
Gross margin74.3%
Source

10-Q filed with the SEC, OTC: RDGL. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Vivos Inc: key numbers

Share price
$0.0405Close, Nov 16
Market cap
$20M
Shares outstanding
494.74MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Vivos Inc

All →
8:55 AM ET 8-K
Capital Raise

Vivos Capital Raise of $1.02M

Vivos Inc. completed a Regulation A+ offering of 12,500,000 shares of common stock for gross proceeds of $1.0 million. Additionally, the company issued warrants to purchase 25,000,000 shares to accredited investors for $25,000 and completed a warrant exchange for 8,000,000 shares of common stock.

Value
$1.02M
4:46 PM ET 8-K
Capital Raise

Vivos Capital Raise

Vivos Inc. entered into a Stock Purchase and Exchange Agreement with a member of its Board of Directors, Carl Cadwell, for the purchase of 250,000 shares of Series D Convertible Preferred Stock for $250,000. Additionally, the director exchanged 385,302 shares of Series C Preferred for an equal number of Series D shares, resulting in the elimination of the Series C class. The Series D shares have a conversion price of $0.08 per share.

Counterparty
Carl Cadwell
5:27 PM ET 8-K
Other 8-K Filing

Vivos Other 8-K Filing

Vivos Inc. filed a Certificate of Designations to create a new class of Series D Convertible Preferred Stock, designating 1.0 million shares with a stated value of $1.00 per share. The filing authorizes the rights and preferences of the new security, including a conversion price of $0.08 per share and super-voting rights equivalent to 50 votes for every share of common stock issuable upon conversion. No shares were reported as issued or sold in this filing.

5:16 PM ET Form 4
Insider Buying

Vivos CEO Michael K. Korenko Buys $99.6K of Stock

Michael K. Korenko, CEO, bought 200,000 shares of Vivos Inc at $0.498 a share, worth $99.6K in total on Sep 30, 2026. Shares held after the trade: 11,635,090 (+1.7%).

Value
$99.6K
Shares
200,000
Price
$0.4980
Role
CEO
Holding change
+1.7%
Trade date
Sep 30, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.